Higher-riskArticle link

Benzodiazepines in Alzheimer's Disease: Risks, Effectiveness, and Safer Alternatives

Benzodiazepines are sometimes prescribed for agitation, anxiety, or sleep in Alzheimer's disease, but they carry serious risks that often outweigh their benefits. These medications can worsen confusion, increase fall risk, and may even accelerate cognitive decline. This article explains why benzodiazepines are generally not recommended, what the research shows about their limited effectiveness, and what concrete steps you can take with your clinician to manage symptoms more safely. You are not alone in facing these challenges, and there are practical, evidence-based strategies to try.

Key points

  • Benzodiazepines are generally not recommended for agitation, anxiety, or sleep in Alzheimer's disease due to high risks of falls, confusion, and cognitive decline.
  • Research shows no consistent evidence that benzodiazepines are effective for behavioral symptoms in dementia; safer alternatives exist.
  • Never stop a benzodiazepine suddenly—withdrawal can be dangerous. Always work with a clinician on a slow taper.
  • Non-drug strategies (identifying triggers, calming routines, pain management) should always be the first line of treatment.
  • If medication is needed, discuss safer options like trazodone for sleep, SSRIs for anxiety/depression, or atypical antipsychotics for severe agitation (with caution).
  • Be an active advocate: keep a symptom diary, ask questions, and request a medication review from a specialist if needed.

Why Benzodiazepines Are Risky in Alzheimer's Disease

Benzodiazepines (such as lorazepam/Ativan, diazepam/Valium, alprazolam/Xanax) work by calming the central nervous system, but in people with Alzheimer's disease, this can backfire. They are known to cause anterograde amnesia—meaning the person may have trouble forming new memories while the drug is active. This is separate from sedation and can worsen the very memory problems Alzheimer's already causes. Additionally, benzodiazepines impair visuospatial ability and sustained attention, even at therapeutic doses taken regularly for more than a year. These effects can make daily functioning harder and increase the risk of falls, especially when the person gets up at night after taking a dose for sleep.

The Evidence: Limited Effectiveness for Agitation and Other Symptoms

A systematic review of randomized controlled trials found no support for the routine use of benzodiazepines to treat behavioral and psychological symptoms of dementia (BPSD). Another review noted some evidence that lorazepam and alprazolam may reduce agitation in Alzheimer's patients, but this is weak and inconsistent. Meanwhile, the risks are well-documented: increased confusion, paradoxical disinhibition (the person becomes more restless or agitated), delirium, and possible acceleration of cognitive decline. In older adults who take benzodiazepines regularly, stopping them suddenly can provoke life-threatening withdrawal symptoms, including increased anxiety and worsening of thinking and behavior. For these reasons, expert guidelines from organizations like the Alzheimer's Association and NICE recommend avoiding benzodiazepines in this population.

How Benzodiazepines Compare to Other Options

Compared to other medications used for agitation or sleep in Alzheimer's, benzodiazepines are among the riskiest. Antipsychotics (like risperidone or aripiprazole) carry their own risks, including increased stroke and death, but they have stronger evidence for severe agitation or psychosis. Antidepressants like citalopram have shown modest benefit for neuropsychiatric symptoms, but at higher doses (above 20 mg/day) they increase cardiac risk. Trazodone is sometimes used for insomnia but can cause orthostatic hypotension. Non-pharmacologic approaches—such as identifying triggers, using calming routines, and ensuring the person's environment is safe and predictable—are always the first line and often more effective than any medication. The goal is to treat the underlying cause of agitation (pain, hunger, boredom, overstimulation) rather than masking it with a drug that can cause harm.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

Step-by-step

  1. Step 1: If your loved one is currently taking a benzodiazepine, do not stop it abruptly. Sudden withdrawal can cause severe anxiety, confusion, and even life-threatening seizures. Instead, schedule an appointment with their prescribing clinician (primary care doctor, geriatrician, or psychiatrist) to discuss a slow, medically supervised taper. The clinician will typically reduce the dose by 10-25% every 1-2 weeks, depending on the person's response.

  2. Step 2: Before the appointment, keep a symptom diary for at least 3-7 days. Write down when agitation, anxiety, or sleep problems occur, what happened just before (the trigger), what you tried, and how the person responded. This helps the clinician distinguish between symptoms that might respond to medication and those that are better managed with environmental changes.

  3. Step 3: Ask the clinician about non-drug strategies first. For agitation, try reducing noise and clutter, offering a favorite snack or drink, playing calming music, or taking a short walk. For anxiety, use a calm voice, validate feelings ('I can see you're worried'), and redirect to a pleasant activity. For sleep problems, maintain a consistent bedtime routine, limit caffeine after noon, and ensure the bedroom is dark and quiet.

  4. Step 4: If medication is still needed, discuss safer alternatives. For severe agitation or psychosis, the clinician may consider an atypical antipsychotic like risperidone or aripiprazole, but only after a careful risk-benefit discussion. For anxiety or restlessness, low-dose trazodone (25-50 mg at bedtime) may help with sleep without the cognitive risks of benzodiazepines. For depression or irritability, an SSRI like citalopram (at doses no higher than 20 mg/day) might be tried, though evidence for efficacy in Alzheimer's is modest.

  5. Step 5: If a benzodiazepine is prescribed for a short-term, specific situation (e.g., before a medical procedure), use the lowest effective dose for the shortest time possible (usually no more than 2-4 weeks). Ask the clinician for a clear plan: when to take it, what dose, and when to stop. Monitor for side effects like increased confusion, falls, or paradoxical agitation, and report these immediately.

  6. Step 6: For sleep, avoid 'Z-drugs' like zolpidem (Ambien) or zaleplon (Sonata) as well. While they are sometimes considered safer, they are chemically related to benzodiazepines and carry similar risks of falls, confusion, and cognitive impairment in older adults with dementia. The FDA has approved Belsomra (suvorexant) for insomnia in mild-to-moderate Alzheimer's, which works differently and may be a better option—ask the clinician about it.

  7. Step 7: Involve the person with Alzheimer's in decisions as much as possible. If they can understand, explain that the medication may help them feel calmer but can also make them more forgetful or unsteady. Use simple language and offer choices ('Would you like to try the medicine tonight, or try a warm bath first?').

  8. Step 8: If the person is in a hospital or care facility, be an active advocate. Ask the staff why a benzodiazepine is being prescribed, what the target symptoms are, and how long it will be used. Request a review of all medications to ensure no unnecessary benzodiazepines are continued. You can say, 'I understand you want to help with his agitation, but I'm worried about the risks. Can we try a non-drug approach first?'

What not to do

  • Do not use benzodiazepines as a first-line treatment for agitation or sleep. They are often prescribed in primary care for these issues, but in Alzheimer's they can worsen confusion, increase fall risk, and cause paradoxical disinhibition. Instead, always try non-drug strategies first and discuss safer medication options with the clinician.

  • Do not combine benzodiazepines with alcohol or other central nervous system depressants (like opioids, other sedatives, or antihistamines). This can lead to dangerous oversedation, respiratory depression, and even fatal overdose. If your loved one drinks alcohol, discuss this with the clinician and consider a plan to reduce or stop drinking.

  • Do not assume that a benzodiazepine prescribed for sleep is safe just because it's a low dose. Even low doses can impair memory consolidation and reduce REM and slow-wave sleep, which are critical for clearing brain waste and maintaining cognitive function. The risk of falls is also present at any dose, especially if the person gets up at night.

  • Do not stop a benzodiazepine suddenly if the person has been taking it regularly for more than a few weeks. Withdrawal can cause severe anxiety, insomnia, confusion, and even seizures. Always work with a clinician to taper the dose slowly over weeks or months.

  • Do not use benzodiazepines to manage behavioral symptoms in someone with Lewy body dementia or Parkinson's disease dementia. These individuals are especially sensitive to side effects like stiffness, tremor, and confusion. Antipsychotics also carry high risks in these populations; quetiapine (Seroquel) is sometimes considered the safest choice, but only under close medical supervision.

Practical tools

  • Symptom and Trigger Diary Template

    Create a simple daily log with columns: Date/Time, Symptom (e.g., agitation, anxiety, pacing), Trigger (e.g., bath time, change in routine, pain), What I Tried (e.g., offered snack, played music, gave medication), and Outcome. Use this to identify patterns and share with the clinician. Example phrase to say: 'I noticed she gets agitated every evening around 6 PM, usually after sitting for a long time. A short walk before dinner seems to help.'

  • Calming Communication Script for Agitation

    When the person is agitated, use a low, slow voice. Say: 'I can see you're feeling upset. Let's sit down together for a moment. Would you like a glass of water or to look at this photo album?' Avoid arguing or correcting. Validate their emotion first, then redirect to a calming activity. This often reduces agitation without any medication.

  • Fall Prevention Checklist for Nighttime

    If the person takes any sedative (including benzodiazepines or Z-drugs) at bedtime, take these steps: (1) Place a nightlight in the bedroom and bathroom. (2) Remove tripping hazards like rugs or cords. (3) Keep a clear path to the bathroom. (4) Consider a bed alarm or a low bed to reduce injury if they fall. (5) Encourage them to use the bathroom before taking the medication. This reduces the risk of falls during nighttime wandering.

  • Medication Review Request Letter

    Write a brief note to the clinician: 'Dear Dr. [Name], I am concerned about [person's name] taking [benzodiazepine name and dose]. I have read that these drugs can increase confusion and fall risk in Alzheimer's. Could we discuss a plan to taper or switch to a safer option? I have kept a symptom diary for the past week and can share it. Thank you for your help.' This empowers you to start the conversation.

  • Non-Drug Sleep Hygiene Routine

    Establish a consistent bedtime routine: same time each night, a warm (not hot) bath or shower, a light snack (like warm milk or a banana), and 15-20 minutes of calming activity (listening to soft music, reading a simple book, or gentle hand massage). Avoid TV or screens at least one hour before bed. This can improve sleep without medication.

  • Pain and Discomfort Checklist

    Before assuming agitation is due to anxiety or dementia, check for physical causes: Is the person hungry, thirsty, or needing to use the bathroom? Are they in pain from arthritis, a urinary tract infection, or constipation? Are they too hot or cold? Use a simple checklist with yes/no questions. Treating the underlying cause often resolves the agitation without any psychiatric medication.

Discuss with your clinician

Ask your clinician: 'What is the specific reason for prescribing a benzodiazepine for my loved one? Is there evidence that it works for this symptom in Alzheimer's?'

Ask: 'What is the plan for tapering or stopping this medication? Can we set a timeline?'

Ask: 'Are there safer alternatives, such as an SSRI, trazodone, or a non-drug approach, that we could try first?'

Ask: 'What are the signs of a serious side effect I should watch for, and when should I call you?'

Ask: 'If my loved one has a history of falls, how do we weigh the risk of falls from the medication against the benefit?'

Ask: 'Is there a risk of withdrawal if we stop the medication, and how will we manage that?'

Ask: 'Can we get a referral to a geriatric psychiatrist or a pharmacist who specializes in dementia for a medication review?'

Related guides

Sources